無料プレビュー

Amneal Pharmaceuticals, Inc. (AMRX) · NASDAQ Global Select

プロフィール

Amneal Pharmaceuticals is a diversified global biopharmaceutical company that develops, manufactures, markets, and distributes essential medicines through three reportable segments: Affordable Medicines (generic pharmaceuticals, injectables, and biosimilars); Specialty (branded products for central nervous system and endocrine disorders); and AvKARE (pharmaceutical distributor serving U.S. federal government and institutional markets). The company operates manufacturing and R&D facilities in the United States, India, and Ireland, and sells products through wholesalers, retail pharmacies, hospi

主要指標

株価: $19.65 (0.00%)
時価総額: 63億ドル
PER（今期予想）: 19.2
PBR: 189.9
配当利回り: —
52週レンジ: $9.56 – $21.18
業種: Healthcare / Drug Manufacturers - Specialty & Generic
上場: NASDAQ Global Select
構成銘柄: —

比較会社: TAK Takeda Pharmaceutical Company Limited、TEVA Teva Pharmaceutical Industries Limited、HLN Haleon plc、ZTS Zoetis Inc.、VTRS Viatris Inc.、ITCI Intra-Cellular Therapies, Inc.、CTLT Catalent, Inc.、ELAN Elanco Animal Health Incorporated

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-29 · 更新: 2026-10-09